Connecting the Rutgers Research Community                                            May 19, 2020
Stay Connected: 

Follow us on Twitter   Like us on Facebook  View our profile on LinkedIn

Search for STEM Experts at Rutgers:



Who's more dangerous, the Asian Hornet or fear itself? 
Photo: Quinlyn Baine, Washington State Department of Agriculture

A ccording to   Dina M. Fonseca , Rutgers' director of the  Center for Vector Biology,   we do not expect 'Vespa Mandarina' on the East Coast.

How do you translate your curiosity into 
success? Share your 
ideas with us! 

How Leaders in Academia, Industry and Students Came Together to Fill the PPE Gap on the COVID-19 Frontlines

by Marisol Seda 
While 'necessity is the mother of invention,' the journey to an inspiring and extraordinary success could be enriched through collaboration and partnerships. This can be attested by Rutgers University and professional services company Accenture, which joined efforts towards the same goal: to solve the necessity of face shields and other personal protection equipment (PPE) for healthcare workers and researchers on the frontlines of the COVID-19 pandemic.
It started with that urgent need and an idea from Joseph Hanna, acute care surgeon and assistant professor at Robert Wood Johnson University Hospital, continued with a combination of passion, expertise and leadership, and has evolved into an organic 'operation bootstrap.' Almost serendipitously, the academia, the corporate world and the community conceived a business model similar to a startup. And now, the operation called RU 3D PPE project, has become an additional force fighting the spread of the deadly virus.
"Fifteen days it took, to go from an initial flurry of emails to the production of 180 sanitized and ready to use laser-cut face shields and 3D printed headbands through a network of 40 3D printers in facilities led by Rutgers Makerspace," said Sacha Patera, associate vice president for Rutgers Corporate Engagement Center.
Sacha Patera, Rutgers Corporate Engagement Center
Kirtan Gandhi, Accenture
Jenna LaPietra, Accenture and Rutgers aluma
Raymond B. Birge

Rutgers HealthAdvance ™  announces its inaugural award to advance the commercialization of anti-cancer therapeutics being developed by researchers Raymond B. Birge from New Jersey Medical School and William Welsh from Robert Wood Johnson Medical School, in collaboration with Youyi Peng at the Rutgers Cancer Institute of New Jersey. HealthAdvance provides up to $200,000 for a two-year period to support the development and de-risking of early-stage life sciences technologies with an impact on human health.

Youyi Peng 
William Welsh
Guided by advanced in silico drug design tools, the research team will use the award for developing a series of first-in-class oncology drugs known as pan-TAM (Tyro3, Axl, Mertk) kinase inhibitors, expected to possess dual modes of action. First, the oncology drugs would work as anticancer agents that act directly on cancer cells to eliminate the tumors and prevent them from metastasizing. They would also work as Immune-Oncology (IO) agents that activate a patient's own adaptive immune system to attack and destroy cancer cells.

OARC COVID-19 Research Projects

The Office of Advanced Research Computing (OARC) team members and resources are involved in a number of emerging COVID-19 essential research projects.  OARC Associate Vice President, J. Barr von Oehsen, is among a team of Rutgers NJ ACTS Informatics leads working on a cross-institutional COVID-19 collaborative project.  The aim of the project is to leverage informatics to extract data for COVID-19 patients from electronic medical records and investigate risk factors and possible treatments for COVID-19 infection. The collaboration is led by NYU and spans across more than 12 large academic medical institutions in New York, New Jersey, and surrounding states. The Rutgers effort is led by Soko Setoguchi, who is coordinating the efforts of the NJ ACTS Informatics leads, Frank A. Sonnenberg, David J. Foran, and Barr von Oehsen, along with hospital IT experts from Robert Wood Johnson Barnabas Health.

Research System Training Available

Need to learn how to use the  Research Administration and Proposal Submission System (RAPSS) or the Effort Reporting system? You can find the schedules for these courses and register online (under Business and Research Administration). Grant and Contract Accounting is also hosting a training session on Subaward Management. To register for this class, visit the Cornerstone Course Registration under ORED - Grants & Contracts. 

The core facility team at ORED has recently launched a grant program to provide  core facilities with support funding up to $100K. Applications will be accepted on a rolling basis until  December 31  and funding decisions will made on a rolling basis within 90 days of submission. All core facilities across all chancellor units at Rutgers are eligible. The  funding is expected to begin by July 1, 2020.

Cities around the world are taking meaningful action to advance health equity by designing solutions that benefit the health of people and our planet. Through this $3 million funding opportunity, the Robert Wood Johnson Foundation seeks to bring the most impactful ideas from across the globe to U.S. cities to address the intertwined issues of health, equity, and climate change. They are seeking proposals that foster learning and stimulate action in U.S. cities around smart, effective approaches from abroad that mitigate the unequal health risks posed by climate change. Specifically, they are seeking proposals that explore changes in city planning, policies, and programs that address: buildings and energy; land use and urban planning; transportation; waste; food systems and food security; and air quality. Applications are due by May 28.

Limited Submission Opportunity: Edward Mallinckrodt, Jr. Foundation

The Edward Mallinckrodt, Jr. Foundation is a private foundation that funds basic biomedical research throughout the United States. The mission of the Foundation is to support early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease. Mallinckrodt Grants are usually $60,000 per year for three years, provided an annual progress report is submitted and approved. The proposal deadline is August 1. Rutgers is limited to submitting one candidate per cycle. Pre-proposals must be submitted through the Rutgers  Limited Submission process. Pre-proposals are due by June 6.

The Busch Biomedical Grant program is designed to enhance biomedical research at the University and to strengthen the competitive position of faculty members who seek external research funds. The Busch Biomedical Grant Program is funded by the interest income from the Charles and Johanna Busch bequest to reflect the wishes of Charles Busch. The Busch Biomedical Grant program will support research projects up to a total of $40,000 for up to two years ($20,000 per year). Applicants must have a Full-Time Faculty appointment. The deadline has been extended to June 15.
to the following researchers for their recently-awarded grants:

Norrinda Hayat - School of Law
Jason Yang  - New Jersey Medical School
Zhihua KangCancer Institute of New Jersey

Learn about their research under  Grant Announcements.
  • Have any exciting research-related news or events you want to share with Rutgers faculty and more than 850 research staff members across the university?
  • Want to add someone to our mailing list?
  • Need help finding someone at ORED   but don't know where to start? 


Send us a message at

We'd love to hear from you!

To view past issues of Research Connections , visit our  Archives

Copyright ©2020 , Rutgers University, an equal opportunity, affirmative action institution. 
Office of Research and Economic Development: